Ryan C. Fields

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression

Yu Zhu, John M. Herndon, Dorothy K. Sojka et al. · Immunity · 2017 · 786 citations · Full text

Medicine, Cancer Biology, Oncology +17

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Timothy M. Nywening, Andrea Wang‐Gillam, Dominic E. Sanford et al. · The Lancet Oncology · 2016 · 778 citations · Full text

Medicine, Oncology, Pharmacology +16

Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

Qingsong Gao, Wen-Wei Liang, Steven M. Foltz et al. · Cell Reports · 2018 · 652 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Targeting both tumour-associated CXCR2⁺ neutrophils and CCR2⁺ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma

Timothy M. Nywening, Brian A. Belt, Darren R. Cullinan et al. · Gut · 2017 · 481 citations · Full text

Medicine, Immunology, Oncology +17

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses <i>in vitro</i> and <i>in vivo</i>

Ryan C. Fields, Koïchi Shimizu, James J. Mulé · Proceedings of the National Academy of Sciences · 1998 · 465 citations · Full text

Life Sciences, Immunology, Oncology +17